Saphetor

Saphetor, founded in 2014, is a precision medicine company at the forefront of genome-scale analysis based on next-generation sequencing (NGS). With the emerging trend of NGS using large "panels" of genes, exomes, or entire genomes, Saphetor’s suite of services provides clinicians with intuitive, data-driven solutions that help them diagnose faster and more accurately, as well as select the best therapies—especially for difficult-to-diagnose conditions such as cancer, rare diseases, or cognitive disorders.